Erythropoietin is equally effective as fresh-blood transfusion at reducing infarct size in anemic rats

Molecular Basis of Cardioprotection by Erythropoietin

(2010) D. Burger et al.   Current Molecular Pharmacology

Does blood transfusion harm cardiac surgery patients?

(2009) Gavin J Murphy   BMC Medicine

Cardiomyocyte-Specific Overexpression of Human Stem Cell Factor Improves Cardiac Function and Survival After Myocardial Infarction in Mice

(2009) Fu-Li Xiang et al.   CIRCULATION

Clinical practice guideline: Red blood cell transfusion in adult trauma and critical care*

(2009) Lena M. Napolitano et al.   CRITICAL CARE MEDICINE

Erythropoietin Protects the Heart from Ventricular Arrhythmia during Ischemia and Reperfusion via Neuronal Nitric-Oxide Synthase

(2009) D. E. Burger et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Effects of anemia and blood transfusion in acute myocardial infarction in rats

(2009) Houxiang Hu et al.   TRANSFUSION

Impact of Red Blood Cell Transfusion on Clinical Outcomes in Patients With Acute Myocardial Infarction

(2008) Doron Aronson et al.   AMERICAN JOURNAL OF CARDIOLOGY

Role of heme oxygenase-1 in the cardioprotective effects of erythropoietin during myocardial ischemia and reperfusion

(2008) Dylan Burger et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Transfusion of packed red blood cells in patients with ischemic heart disease

(2008) David R. Gerber   CRITICAL CARE MEDICINE

Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response

(2008) M. Brines et al.   JOURNAL OF INTERNAL MEDICINE